Sort by: Latest openings
bionyra.com
bionyra.com • Immunology & Inflammation Therapeutics • Biologics & Biosimilars • Startup • New • Jeito Capital · Sofinnova Partners
Bionyra Pharma is a clinical-stage biopharmaceutical company developing next-generation biologics for severe immune-mediated inflammatory diseases. Bionyra’s.
No named decision-maker yet.
Careers mailbox is known
Follow
···
repronovo.com
repronovo.com • Women’s Health & Maternity • Health Care • Founded 2021 • Likely startup • New • Jeito Capital · M Ventures +1
New Scientific Approaches in Reproductive Medicine. At ReproNovo, we are passionate about bringing the dream of parenthood to life.
Jean Duvall · Chief Executive Officer · decision-maker · no contact
Careers mailbox is known
Follow
···
xylocor.com
xylocor.com • Biotechnology • Cell & Gene Therapy • Likely startup • New • Jeito Capital · Lumira Ventures +1
Gene therapy for advanced coronary artery disease. XyloCor Therapeutics is focused on improving the lives of patients through our commitment to advancing novel therapies for coronary artery disease.
No named decision-maker yet.
Careers mailbox is known
Follow
···
nmdpharma.com
nmdpharma.com • Rare Disease Therapeutics • Drug Discovery • 51-200 employees • Likely startup • New • Inkef · Jeito Capital
0 Enable better lives through novel therapies to restore skeletal muscle health About NMD Pharma NMD Pharma is a clinical-stage biotech company dedicated to enabling better lives through novel therapies designed to restore skeletal muscle health.
No named decision-maker yet.
Careers mailbox is known
Follow
···
advesya.com
advesya.com • Biotechnology • Health Care • Founded 2020 • Likely startup • New • Jeito Capital
Advesya is transforming the fight against cancer and autoimmune diseases. Building on years of academic research, advesya’s innovative work targets IL-1RAP.
No named decision-maker yet.
Careers mailbox is known
Follow
···
quell-tx.com
quell-tx.com • London • Biotechnology • Immunology & Inflammation Therapeutics • Likely startup • New • Albion · Jeito Capital
Quell Therapeutics is a clinical-stage company, fuelled by curiosity and discovery, on a mission to make life better for those battling severe immune and inflammatory disease.
No named decision-maker yet.
Careers mailbox is known
Sep 26 Moved to Greenhouse
Board re-checked 5 hours ago · 1 event in 14 days
Follow
···
pulmocide.com
pulmocide.com • Biotechnology • Health Care • 201-500 employees • Likely startup • New • Jeito Capital
Pulmocide is a biotechnology company developing novel inhaled medicines for pulmonary aspergillosis and other hard-to-treat respiratory diseases.
No named decision-maker yet.
Careers mailbox is known
Follow
···
alentis.ch • Biologics & Biosimilars • Biotechnology • 51-200 employees • Founded 2019 • Likely startup • New • RA Capital Management · Jeito Capital +2
THE CLAUDIN-1 COMPANY Treat cancer and reverse fibrosis We are a clinical-stage biotech company with a mission to treat cancer and reverse fibrosis. To this end, we are rapidly advancing our pipeline of anti-Claudin-1 antibody-drug conjugates (ADCs) and monoclonal antibodies.
No named decision-maker yet.
Careers mailbox is known
Follow
···
augustinetx.com
augustinetx.com • Biotechnology • Cardiometabolic Therapeutics • 11-50 employees • Founded 2019 • Likely startup • New • Asabys Partners · Jeito Capital +1
Augustine Therapeutics is developing selective, safe and efficacious HDAC6 inhibitors designed for treatment of neuromuscular, neurodegenerative and cardiometabolic diseases. Discover our pipeline poised for clinical impact.
No named decision-maker yet.
Careers mailbox is known
Follow
···
odysseytx.com
odysseytx.com • Drug Discovery • Biotechnology • Likely startup • New • Activant Capital · Jeito Capital +1
Odyssey is on a mission to transform the standard of care for patients affected by autoimmune and inflammatory conditions.
No named decision-maker yet.
Careers mailbox is known
Follow
···
noemapharma.com
noemapharma.com • Basel, Switzerland • Rare Disease Therapeutics • Neurology & CNS Therapeutics • 11-50 employees • Founded 2019 • Startup • New • Series B · 22 mo ago • Jeito Capital · Sofinnova Partners
DRIVING BETTER OUTCOMES Advancing therapeutics designed to deliver superior clinical benefit across both orphan and broader neurology indications Who we are ...
No named decision-maker yet.
Careers mailbox is known
Sep 16 Posted a role, closed 1 Director of Regulatory Affairs
Board re-checked 1 day ago · 2 events in 14 days
Follow
1 role
···
alveustx.com
alveustx.com • Paris, France • Cardiometabolic Therapeutics • Prescription Drugs • 11-50 employees • Founded 2014 • Startup • Venture round $160M · 8 mo ago • Jeito Capital
At Alveus Therapeutics, we are building a differentiated therapeutic portfolio that delivers sustainable weight loss with superior tolerability.
No named decision-maker yet.
Careers mailbox is known
Board re-checked 6 min ago · 1 event in 14 days
Follow
···